What are the clinical findings in cardiogenic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clinical Findings in Cardiogenic Shock

Cardiogenic shock presents with the triad of persistent hypotension (systolic blood pressure <90 mmHg for >30 minutes or requiring vasopressors/inotropes), signs of end-organ hypoperfusion, and elevated cardiac filling pressures. 1

Hemodynamic Profile

The defining hemodynamic pattern distinguishes cardiogenic shock from other shock states:

  • Cardiac index <2.2 L/min/m² (often <1.8 L/min/m² in severe cases), reflecting the failing myocardium's inability to generate adequate output 1, 2
  • Cardiac power output <0.6 W is the most critical threshold for identifying refractory shock 1
  • Elevated pulmonary capillary wedge pressure (PCWP) >15 mmHg (often >20 mmHg), indicating left ventricular failure and pulmonary congestion 1, 2
  • Increased systemic vascular resistance (SVR) as a compensatory mechanism attempting to maintain blood pressure despite falling cardiac output 1
  • Elevated central venous pressure (CVP) >15 mmHg from right-sided filling pressures and backward failure 1

Clinical Manifestations of Hypoperfusion

Cardiovascular Signs

  • Profound hypotension with systolic blood pressure <90 mmHg despite compensatory mechanisms 1
  • Tachycardia as the body attempts to maintain cardiac output when stroke volume is reduced 1
  • Decreased pulse pressure reflecting reduced stroke volume and increased arterial stiffness from vasoconstriction 1
  • Cold, clammy extremities with peripheral cyanosis from peripheral vasoconstriction 1, 3

Pulmonary Findings

  • Pulmonary edema with crackles on auscultation from elevated left ventricular filling pressures 1
  • Jugular venous distension indicating elevated right-sided pressures 1

End-Organ Hypoperfusion Markers

Neurologic:

  • Altered mental status ranging from confusion to obtundation from cerebral hypoperfusion 1, 3

Renal:

  • Oliguria with urine output <0.5 mL/kg/h indicating inadequate renal perfusion 1
  • Acute kidney injury with rising creatinine 1

Hepatic:

  • Elevated bilirubin ≥1.3 mg/dL independently predicts 180-day cardiac mortality 1
  • Acute liver injury as part of multiorgan dysfunction 1

Metabolic:

  • Elevated lactate >2 mmol/L indicating tissue hypoperfusion and anaerobic metabolism 2, 1
  • Decreased mixed venous oxygen saturation (SvO2) <70% indicating inadequate oxygen delivery with increased tissue oxygen extraction 1

SCAI Classification Staging

The Society for Cardiovascular Angiography and Interventions provides a nuanced staging system that correlates with clinical findings 1:

  • Stage A (At Risk): Normal hemodynamics, normotension, clear lungs, normal perfusion
  • Stage B (Beginning Shock): Relative hypotension, tachycardia, early hypoperfusion signs
  • Stage C (Classic Shock): Hypotension requiring intervention, hypoperfusion with oliguria, altered mental status
  • Stage D (Deteriorating/Doom): Worsening despite initial interventions, requiring escalating support
  • Stage E (Extremis): Cardiac arrest, refractory hypotension requiring CPR and/or ECMO 1

Phenotype-Specific Findings

Left Ventricular-Dominant Shock

  • PCWP >15 mmHg with RA <15 mmHg 2
  • Prominent pulmonary congestion and edema 1

Right Ventricular-Dominant Shock

  • RA pressure >15 mmHg with PCWP <15 mmHg 2
  • Jugular venous distension without pulmonary edema 2
  • Clear lung fields despite shock state 2

Biventricular Shock

  • Both RA >15 mmHg and PCWP >15 mmHg 2
  • Combined features of left and right heart failure 2

Critical Diagnostic Pitfalls

Avoid confusing late-stage septic shock with cardiogenic shock, as septic shock can develop myocardial depression but the primary hemodynamic pattern remains distributive with decreased SVR, not the elevated SVR seen in cardiogenic shock 1. The key distinguishing feature is that cardiogenic shock demonstrates elevated filling pressures (PCWP >15 mmHg, CVP >15 mmHg) while hypovolemic and distributive shock show decreased filling pressures 1.

Dynamic changes in hemodynamic parameters occur rapidly as shock progresses or responds to treatment, emphasizing the need for continuous monitoring rather than single-point assessment 1.

References

Guideline

Hemodynamic Differentiation of Shock Types

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Cardiogenic Shock vs Heart Failure: Key Differences

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.